Markets on the Rise
BSE Sensex ends above 18,000
The BSE Sensex rose for the third straight session on Wednesday, up 2 percent to its highest level in more than six months, as falling inflation bolstered appetite for shares in interest rate-sensitive sectors such as banks, automobiles and infrastructure. Full Article
Reuters Showcase
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Glenmark gets US nod for steroid skin cream
MUMBAI, Sept 25 |
MUMBAI, Sept 25 (Reuters) - Glenmark Pharmaceuticals Ltd (GLEN.BO) said on Thursday its generics unit has received approval from the U.S. Food and Drug Administration for sale of betamethasone dipropionate skin cream in the U.S.
The drug, a generic form of Schering-Plough's SGP.N Diprolene AF cream, is a corticosteroid used to treat swelling, itching and allergic reactions.
It is the eighth steroidal skin product in the company's portfolio targeting an overall segment value of $60 million, the drugmaker said in a statement.
Glenmark has over 35 abbreviated new drug applications pending approval with the US FDA, of which a fifth fall within the dermatology segment.
Shares in the company were up 1.98 percent at 594.20 rupees in a weak Mumbai market. (Reporting by Swati Pandey; Editing by Ramya Venugopal)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters